NCT03338595View on ClinicalTrials.gov

Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CF

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
Cystic Fibrosis
Trial Locations (1)

30912

Georgia Prevention Institute, Augusta

All Listed Sponsors
collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

lead

Augusta University

OTHER

NCT03338595 - Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CF | Biotech Hunter | Biotech Hunter